Concentrix Guides Q4 Adjusted EPS to $2.86-$2.98
CNXC sits 31% above its 52-week low of $19.12.
Summary
Concentrix issued Q4 adjusted EPS guidance of $2.86 to $2.98, a forward-looking estimate not previously disclosed. This follows Q2 results showing 1.9% revenue growth and a 36.5% jump in diluted EPS, along with the recent CastleHill acquisition and an executive departure. The guidance provides a concrete earnings target for the current quarter, which traders can use to benchmark performance. No specific upcoming event is named, but the range itself is the key data point. Concentrix cut its full-year revenue guidance and swung to a loss in the third quarter.
At the time of this announcement, CNXC was trading at $25.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $19.12 to $49.37. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.